- €49.40m
- €87.08m
- €118.78m
- 73
- 49
- 28
- 47
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 88.6 | 61.6 | 79.8 | 106 | 119 |
Cost of Revenue | |||||
Gross Profit | 55.8 | 36.2 | 50.5 | 67.2 | 74.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 84.5 | 67.5 | 75.6 | 97.3 | 112 |
Operating Profit | 4.02 | -5.98 | 4.2 | 8.19 | 6.61 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 4.07 | -6.3 | 3.78 | 7.42 | 4.54 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.1 | -4.41 | 2.59 | 5.37 | 3.14 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 3.1 | -4.41 | 2.59 | 5.38 | 3.04 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.1 | -4.41 | 2.59 | 5.38 | 3.04 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.349 | -0.503 | 0.289 | 0.603 | 0.342 |
Dividends per Share |